Shockwave Medical (SWAV) Positive Preannouncement Highlights COVID-19 Recovery - Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst David Lewis reiterated an Overweight rating and $130.00 price target on Shockwave Medical (NASDAQ: SWAV) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
